HE Jun-jun,WANG Hong,HU Yuan-yuan,et al.Effects of esketamine combined with sufentanil on postoperative analgesia and depression after hip arthroplasty[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2024,33(03):268-271.
HE Jun-jun,WANG Hong,HU Yuan-yuan,et al.Effects of esketamine combined with sufentanil on postoperative analgesia and depression after hip arthroplasty[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2024,33(03):268-271. DOI: 10.11659/jjssx.05E023098.
Effects of esketamine combined with sufentanil on postoperative analgesia and depression after hip arthroplasty
To evaluate the effects of ketamine combined with sufentanil on postoperative analgesia and depression in patients undergoing hip arthroplasty.
Methods
2
A total of 60 patients who underwent elective hip arthroplasty were selected and divided into the S group, the SK1 group and the SK2 group according to the patient-controlled intravenous analgesia regimen, with 20 cases in each group. Patients in the S group were received 2 μg/kg of sufentanil for postoperative analgesia, patients in the SK1 group were received 1 mg/kg of esketamine and 2 μg/kg of sufentanil for postoperative analgesia, and patients in the SK2 group were received 2 mg/kg of esketamine and 2 μg/kg of sufentanil for postoperative analgesia. At 1, 4, 24, and 48 hours after surgery, the analgesic effect of patients was evaluated using the numeric rating scale (NRS), and the sedation effect of patients was evaluated using the Ramsay sedation score. Depression of patients before and 48 hours after surgery was assessed by self-rating depression scale (SDS). The adverse reactions such as nausea and vomiting, dizziness and headache, respiratory depression, and mental symptoms within 48 hours after surgery of patients were recorded.
Results
2
The NRS scores 1, 4, and 24 hours after surgery of patients in the SK1 group and the SK2 group were lower than those in the S group (
P
<
0.05); there was no statistically significant difference in the NRS scores 48 hours after surgery of patients among the three groups (
P
>
0.05);there was no statistically significant difference in the NRS scores at different postoperative points of patients between the SK1 and SK2 groups (
P
>
0.05). The SDS scores 48 hours after surgery of patients in each group were lower than those before surgery (
P
<
0.05).There was no statistically significant difference in the Ramsay scores at different postoperative points of patients among the three groups (
P
>
0.05). The incidence of adverse reactions 48 hours after surgery in the SK2 group was higher than those in the S group and the SK1 group (
P
<
0.05).
Conclusion
2
Using 1 mg/kg of esketamine combined with 2 μg/kg of sufentanil after hip arthroplasty has a good analgesic effect without obvious increase of adverse reactions or significant effect on improving depression of patients.
Lau YS,Harrison M,Sutton M.Association between symptom duration and patient-reported outcomes before and after hip replacement surgery[J].Arthritis Care Res (Hoboken),2020,72(3):423-431.doi:10.1002/acr.23838http://dx.doi.org/10.1002/acr.23838.
Wang X,Lin C,Lan L,et al.Perioperative intravenous S-ketamine for acute postoperative pain in adults:a systematic review and meta-analysis[J].J Clin Anesth,2021,68:110071.doi:10.1016/j.jclinane.2020.110071http://dx.doi.org/10.1016/j.jclinane.2020.110071.
Lei Y,Liu H,Xia F,et al.Effects of esketamine on acute and chronic pain after thoracoscopy pulmonary surgery under general anesthesia:a multicenter-prospective,randomized,double-blind,and controlled trial[J].Front Med (Lausanne),2021,8:693594.doi:10.3389/fmed.2021.693594http://dx.doi.org/10.3389/fmed.2021.693594.
Erlenwein J,Müller M,Falla D,et al.Clinical relevance of persistent postoperative pain after total hipreplacement-a prospective observational cohort study[J].J Pain Res,2017,10:2183-2193.doi:10.2147/JPR.S137892http://dx.doi.org/10.2147/JPR.S137892.
Thomas WW,Mike G,David AM,et al.Consensus statement for perioperative care in total hip replacement and total knee replacement surgery:Enhanced Recovery After Surgery (ERAS®) Society recommendations[J].Acta Orthop,2020,91(1):3-19.doi:10.1080/17453674.2019.1683790http://dx.doi.org/10.1080/17453674.2019.1683790.
Zhen L,Li X,Gao X,et al.Dose determination of sufentanil for intravenous patient-controlled analgesia with background infusion in abdominal surgeries:a random study[J].PLoS One,2018,13(10):e0205959.doi:10.1371/journal.pone.0205959http://dx.doi.org/10.1371/journal.pone.0205959.
Gao Y,Deng X,Yuan H,et al.Patient-controlled intravenous analgesia with combination of dexmedetomidine and sufentanil on patients after abdominal operation:aprospective,randomized,controlled,blinded,multicenter clinical study[J].Clin J Pain,2018,34(2):155-161.doi:10.1097/AJP.0000000000000527http://dx.doi.org/10.1097/AJP.0000000000000527.
Imani F,Varrassi G.Ketamine as adjuvant for acute pain management[J].Anesth Pain Med,2019,9:e100178.doi:10.5812/aapm.100178http://dx.doi.org/10.5812/aapm.100178.
Aronsohn J,Orner G,Palleschi G,et al.Opioid-free total intravenous anesthesia with ketamine as part of an enhanced recovery protocol for bariatric surgery patients with sleep disordered breathing[J].J Clin Anesth,2019,52:65-66.doi:10.1016/j.jclinane.2018.09.014http://dx.doi.org/10.1016/j.jclinane.2018.09.014.
Gagliese L,Weizblit N,Ellis W,et al.The measurement of postoperative pain:a comparison of intensity scales in younger and older surgical patients[J].Pain,2005,117(3):412-420.doi:10.1016/j.pain.2005.07.004http://dx.doi.org/10.1016/j.pain.2005.07.004.
Han Y,Li P,Miao M,et al.S-ketamine as an adjuvant in patient-controlled intravenous analgesia for preventing postpartum depression:a randomized controlled trial[J].BMC Anesthesiol,2022,22(1):49.doi:10.1186/s12871-022-01588-7http://dx.doi.org/10.1186/s12871-022-01588-7.
Brinck EC,Tiippana E,Heesen M,et al.Perioperative intravenous ketamine for acute postoperative pain in adults[J].Cochrane Database Syst Rev,2018,12:CD012033.doi:10.1002/14651858.CD012033.pub4http://dx.doi.org/10.1002/14651858.CD012033.pub4.
Bornemann-Cimenti H,Wejbora M,Michaeli K,et al.The effects of minimal-dose versus low-dose S-ketamine on opioid consumption,hyperalgesia,and postoperative delirium:a triple-blinded,randomized,active- and placebo-controlled clinical trial[J].Minerva Anestesiol,2016,82(10):1069-1076.
Dunstan DA,Scott N,Todd AK.Screening for anxiety and depression:reassessing the utility of the Zung scales[J].BMC Psychiatry,2017,17:329.doi:10.1186/s12888-017-1489-6http://dx.doi.org/10.1186/s12888-017-1489-6.
Ng J,Rosenblat JD,Lui LMW,et al.Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression:a systematic review[J].J Affect Disord,2021,293:285-294.doi:10.1016/j.jad.2021.06.032http://dx.doi.org/10.1016/j.jad.2021.06.032.
Alipoor M,Loripoor M,Kazemi M,et al.The effect of ketamine on preventing postpartum depression[J].J Med Life,2021,14(1):87-92.doi:10.25122/jml-2020-0116http://dx.doi.org/10.25122/jml-2020-0116.